-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Following the approval of the registration of formula milk powder by many companies such as Aidiha on April 1, on April 8, the State Administration for Market Regulation announced the list of the 47th batch of approved formula registration, including those from Duerbot Yili Dairy Co.
The following is the original text of the announcement issued by the State Drug Administration:
undefined
Among them, Yili's products registered by formula are: Jinlingguan Senamu 1, 2, and 3 paragraphs; Mead Johnson's products registered by formula are Qinshu 3 paragraphs; Ou Beijia's products registered by formula are Ou Shida (goat milk powder) 1, 2, 3 paragraphs , Zhixu Bezi 1, 2, 3 and Zhi Hu 1, 2, 3
In fact, within a week, the registration of the second batch of infant milk powder formula was approved
In 2016, in order to solve the problems of excessive and excessive formulas of infant formula milk powder in China, the formulation of formulas is random and frequent replacement, making it difficult for consumers to choose, the former State Food and Drug Administration announced the "Regulation of Infant Formula Milk Powder Product Formula".
The "Measures" stipulate that no matter whether it is a domestic or foreign brand, in principle, each enterprise shall not exceed three formula series and nine product formulas
Previously, limited by the mandatory registration verification tasks and overseas factory verification and other exit indicators, the industry generally believed that the formulation registration was slow
In November 2018, Xiong Maoping, director of the Registration Bureau of the State Administration for Market Regulation, said that the State Administration for Market Regulation will further deepen the reform of the review and approval of drugs and medical devices and special foods, optimize drug registration and medical device review and approval, and optimize the approval of special food registration.
